Topotecan

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

17 Suppliers, 8 USDMF, 1 EU WC, 4 KDMF, 3 NDC API, 11 Listed Suppliers

DEVELOPMENTS

14 Drug(s) in Development

14 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

3 Suppliers

3 Suppliers

DOSSIERs // Finished Dosage Forms

68 Dossiers, 22 FDA Orange Book, 27 Europe, 5 Canada, 4 Australia, 4 South Africa, 6 Listed Dossiers

DRUG PRODUCT COMPOSITION

SOLUTION;INTRAVENOUS - EQ 1MG BASE/ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - EQ 3MG BASE/3ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - EQ 4MG BASE/4ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - EQ 4MG BASE/4ML (EQ 1MG BASE/ML), INJECTABLE;INJECTION - EQ 4MG BASE/VIAL, CAPSULE;ORAL - EQ 0.25MG BASE, CAPSULE;ORAL - EQ 1MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 13 SPI Pharma, 6 Kerry, 5 Roquette, 4 ACG Worldwide, 3 Lonza Capsugel, 3 Gangwal Chemicals, 2 BASF, 2 Microlex e.U, 2 Gangwal Healthcare, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Qualicaps, 1 Rochem International Inc, 1 Ingredion Pharma Solutions, 1 Actylis, 1 Sigachi Industries, 1 Pfanstiehl, 1 DKSH

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders, 10 Direct Compression, 10 Chewable & Orodispersible Aids, 10 Taste Masking, 8 Co-Processed Excipients, 8 Empty Capsules, 4 Coating Systems & Additives, 4 Parenteral, 3 Disintegrants & Superdisintegrants, 3 Granulation, 2 Film Formers & Plasticizers, 2 Solubilizers, 1 Topical, 1 Thickeners and Stabilizers, 1 API Stability Enhancers

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 16 Finished Drug Prices

MARKET PLACE

3 APIs, 5 DOSSIERS // FDF

PATENTS

2 US Patents, 3 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 USP Standards, 4 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 21 News

Information, Expiry & Status of FDA Orange Book Patents covering Topotecan

Topotecan

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

17 Suppliers

8 USDMF

1 EU WC

4 KDMF

3 NDC API

11 Listed Suppliers

DEVELOPMENTS

14 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

3 Suppliers

DOSSIERs // Finished Dosage Forms

68 Dossiers

22 FDA Orange Book

27 Europe

5 Canada

4 Australia

4 South Africa

6 Listed Dossiers

DRUG PRODUCT COMPOSITION

SOLUTION;INTRAVENOUS - EQ 1MG BASE/ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - EQ 3MG BASE/3ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - EQ 4MG BASE/4ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - EQ 4MG BASE/4ML (EQ 1MG BASE/ML)

INJECTABLE;INJECTION - EQ 4MG BASE/VIAL

CAPSULE;ORAL - EQ 0.25MG BASE

CAPSULE;ORAL - EQ 1MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

13 SPI Pharma

6 Kerry

5 Roquette

4 ACG Worldwide

3 Lonza Capsugel

3 Gangwal Chemicals

2 BASF

2 Microlex e.U

2 Gangwal Healthcare

1 Shijiazhuang Huaxu Pharmaceutical

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Qualicaps

1 Rochem International Inc

1 Ingredion Pharma Solutions

1 Actylis

1 Sigachi Industries

1 Pfanstiehl

1 DKSH

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders

10 Direct Compression

10 Chewable & Orodispersible Aids

10 Taste Masking

8 Co-Processed Excipients

8 Empty Capsules

4 Coating Systems & Additives

4 Parenteral

3 Disintegrants & Superdisintegrants

3 Granulation

2 Film Formers & Plasticizers

2 Solubilizers

1 Topical

1 Thickeners and Stabilizers

1 API Stability Enhancers

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions

16 Finished Drug Prices

MARKET PLACE

3 APIs

5 DOSSIERS // FDF

PATENTS

2 US Patents

3 Health Canada Patents

SOLUTION;INTRAVENOUS - EQ 1MG BASE/ML (EQ 1MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - EQ 3MG BASE/3ML (EQ 1MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - EQ 4MG BASE/4ML (EQ 1MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons